table of content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global End-Stage Renal Disease (ESRD) Drugs Market Size Analysis from 2022 to 2027
1.5.1 Global End-Stage Renal Disease (ESRD) Drugs Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global End-Stage Renal Disease (ESRD) Drugs Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global End-Stage Renal Disease (ESRD) Drugs Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: End-Stage Renal Disease (ESRD) Drugs Industry Impact
Chapter 2 Global End-Stage Renal Disease (ESRD) Drugs Competition by Types, Applications, and Top Regions and Countries
2.1 Global End-Stage Renal Disease (ESRD) Drugs (Volume and Value) by Type
2.1.1 Global End-Stage Renal Disease (ESRD) Drugs Consumption and Market Share by Type (2016-2021)
2.1.2 Global End-Stage Renal Disease (ESRD) Drugs Revenue and Market Share by Type (2016-2021)
2.2 Global End-Stage Renal Disease (ESRD) Drugs (Volume and Value) by Application
2.2.1 Global End-Stage Renal Disease (ESRD) Drugs Consumption and Market Share by Application (2016-2021)
2.2.2 Global End-Stage Renal Disease (ESRD) Drugs Revenue and Market Share by Application (2016-2021)
2.3 Global End-Stage Renal Disease (ESRD) Drugs (Volume and Value) by Regions
2.3.1 Global End-Stage Renal Disease (ESRD) Drugs Consumption and Market Share by Regions (2016-2021)
2.3.2 Global End-Stage Renal Disease (ESRD) Drugs Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global End-Stage Renal Disease (ESRD) Drugs Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global End-Stage Renal Disease (ESRD) Drugs Consumption by Regions (2016-2021)
4.2 North America End-Stage Renal Disease (ESRD) Drugs Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia End-Stage Renal Disease (ESRD) Drugs Sales, Consumption, Export, Import (2016-2021)
4.4 Europe End-Stage Renal Disease (ESRD) Drugs Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia End-Stage Renal Disease (ESRD) Drugs Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia End-Stage Renal Disease (ESRD) Drugs Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East End-Stage Renal Disease (ESRD) Drugs Sales, Consumption, Export, Import (2016-2021)
4.8 Africa End-Stage Renal Disease (ESRD) Drugs Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania End-Stage Renal Disease (ESRD) Drugs Sales, Consumption, Export, Import (2016-2021)
4.10 South America End-Stage Renal Disease (ESRD) Drugs Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America End-Stage Renal Disease (ESRD) Drugs Market Analysis
5.1 North America End-Stage Renal Disease (ESRD) Drugs Consumption and Value Analysis
5.1.1 North America End-Stage Renal Disease (ESRD) Drugs Market Under COVID-19
5.2 North America End-Stage Renal Disease (ESRD) Drugs Consumption Volume by Types
5.3 North America End-Stage Renal Disease (ESRD) Drugs Consumption Structure by Application
5.4 North America End-Stage Renal Disease (ESRD) Drugs Consumption by Top Countries
5.4.1 United States End-Stage Renal Disease (ESRD) Drugs Consumption Volume from 2016 to 2021
5.4.2 Canada End-Stage Renal Disease (ESRD) Drugs Consumption Volume from 2016 to 2021
5.4.3 Mexico End-Stage Renal Disease (ESRD) Drugs Consumption Volume from 2016 to 2021
Chapter 6 East Asia End-Stage Renal Disease (ESRD) Drugs Market Analysis
6.1 East Asia End-Stage Renal Disease (ESRD) Drugs Consumption and Value Analysis
6.1.1 East Asia End-Stage Renal Disease (ESRD) Drugs Market Under COVID-19
6.2 East Asia End-Stage Renal Disease (ESRD) Drugs Consumption Volume by Types
6.3 East Asia End-Stage Renal Disease (ESRD) Drugs Consumption Structure by Application
6.4 East Asia End-Stage Renal Disease (ESRD) Drugs Consumption by Top Countries
6.4.1 China End-Stage Renal Disease (ESRD) Drugs Consumption Volume from 2016 to 2021
6.4.2 Japan End-Stage Renal Disease (ESRD) Drugs Consumption Volume from 2016 to 2021
6.4.3 South Korea End-Stage Renal Disease (ESRD) Drugs Consumption Volume from 2016 to 2021
Chapter 7 Europe End-Stage Renal Disease (ESRD) Drugs Market Analysis
7.1 Europe End-Stage Renal Disease (ESRD) Drugs Consumption and Value Analysis
7.1.1 Europe End-Stage Renal Disease (ESRD) Drugs Market Under COVID-19
7.2 Europe End-Stage Renal Disease (ESRD) Drugs Consumption Volume by Types
7.3 Europe End-Stage Renal Disease (ESRD) Drugs Consumption Structure by Application
7.4 Europe End-Stage Renal Disease (ESRD) Drugs Consumption by Top Countries
7.4.1 Germany End-Stage Renal Disease (ESRD) Drugs Consumption Volume from 2016 to 2021
7.4.2 UK End-Stage Renal Disease (ESRD) Drugs Consumption Volume from 2016 to 2021
7.4.3 France End-Stage Renal Disease (ESRD) Drugs Consumption Volume from 2016 to 2021
7.4.4 Italy End-Stage Renal Disease (ESRD) Drugs Consumption Volume from 2016 to 2021
7.4.5 Russia End-Stage Renal Disease (ESRD) Drugs Consumption Volume from 2016 to 2021
7.4.6 Spain End-Stage Renal Disease (ESRD) Drugs Consumption Volume from 2016 to 2021
7.4.7 Netherlands End-Stage Renal Disease (ESRD) Drugs Consumption Volume from 2016 to 2021
7.4.8 Switzerland End-Stage Renal Disease (ESRD) Drugs Consumption Volume from 2016 to 2021
7.4.9 Poland End-Stage Renal Disease (ESRD) Drugs Consumption Volume from 2016 to 2021
Chapter 8 South Asia End-Stage Renal Disease (ESRD) Drugs Market Analysis
8.1 South Asia End-Stage Renal Disease (ESRD) Drugs Consumption and Value Analysis
8.1.1 South Asia End-Stage Renal Disease (ESRD) Drugs Market Under COVID-19
8.2 South Asia End-Stage Renal Disease (ESRD) Drugs Consumption Volume by Types
8.3 South Asia End-Stage Renal Disease (ESRD) Drugs Consumption Structure by Application
8.4 South Asia End-Stage Renal Disease (ESRD) Drugs Consumption by Top Countries
8.4.1 India End-Stage Renal Disease (ESRD) Drugs Consumption Volume from 2016 to 2021
8.4.2 Pakistan End-Stage Renal Disease (ESRD) Drugs Consumption Volume from 2016 to 2021
8.4.3 Bangladesh End-Stage Renal Disease (ESRD) Drugs Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia End-Stage Renal Disease (ESRD) Drugs Market Analysis
9.1 Southeast Asia End-Stage Renal Disease (ESRD) Drugs Consumption and Value Analysis
9.1.1 Southeast Asia End-Stage Renal Disease (ESRD) Drugs Market Under COVID-19
9.2 Southeast Asia End-Stage Renal Disease (ESRD) Drugs Consumption Volume by Types
9.3 Southeast Asia End-Stage Renal Disease (ESRD) Drugs Consumption Structure by Application
9.4 Southeast Asia End-Stage Renal Disease (ESRD) Drugs Consumption by Top Countries
9.4.1 Indonesia End-Stage Renal Disease (ESRD) Drugs Consumption Volume from 2016 to 2021
9.4.2 Thailand End-Stage Renal Disease (ESRD) Drugs Consumption Volume from 2016 to 2021
9.4.3 Singapore End-Stage Renal Disease (ESRD) Drugs Consumption Volume from 2016 to 2021
9.4.4 Malaysia End-Stage Renal Disease (ESRD) Drugs Consumption Volume from 2016 to 2021
9.4.5 Philippines End-Stage Renal Disease (ESRD) Drugs Consumption Volume from 2016 to 2021
9.4.6 Vietnam End-Stage Renal Disease (ESRD) Drugs Consumption Volume from 2016 to 2021
9.4.7 Myanmar End-Stage Renal Disease (ESRD) Drugs Consumption Volume from 2016 to 2021
Chapter 10 Middle East End-Stage Renal Disease (ESRD) Drugs Market Analysis
10.1 Middle East End-Stage Renal Disease (ESRD) Drugs Consumption and Value Analysis
10.1.1 Middle East End-Stage Renal Disease (ESRD) Drugs Market Under COVID-19
10.2 Middle East End-Stage Renal Disease (ESRD) Drugs Consumption Volume by Types
10.3 Middle East End-Stage Renal Disease (ESRD) Drugs Consumption Structure by Application
10.4 Middle East End-Stage Renal Disease (ESRD) Drugs Consumption by Top Countries
10.4.1 Turkey End-Stage Renal Disease (ESRD) Drugs Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia End-Stage Renal Disease (ESRD) Drugs Consumption Volume from 2016 to 2021
10.4.3 Iran End-Stage Renal Disease (ESRD) Drugs Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates End-Stage Renal Disease (ESRD) Drugs Consumption Volume from 2016 to 2021
10.4.5 Israel End-Stage Renal Disease (ESRD) Drugs Consumption Volume from 2016 to 2021
10.4.6 Iraq End-Stage Renal Disease (ESRD) Drugs Consumption Volume from 2016 to 2021
10.4.7 Qatar End-Stage Renal Disease (ESRD) Drugs Consumption Volume from 2016 to 2021
10.4.8 Kuwait End-Stage Renal Disease (ESRD) Drugs Consumption Volume from 2016 to 2021
10.4.9 Oman End-Stage Renal Disease (ESRD) Drugs Consumption Volume from 2016 to 2021
Chapter 11 Africa End-Stage Renal Disease (ESRD) Drugs Market Analysis
11.1 Africa End-Stage Renal Disease (ESRD) Drugs Consumption and Value Analysis
11.1.1 Africa End-Stage Renal Disease (ESRD) Drugs Market Under COVID-19
11.2 Africa End-Stage Renal Disease (ESRD) Drugs Consumption Volume by Types
11.3 Africa End-Stage Renal Disease (ESRD) Drugs Consumption Structure by Application
11.4 Africa End-Stage Renal Disease (ESRD) Drugs Consumption by Top Countries
11.4.1 Nigeria End-Stage Renal Disease (ESRD) Drugs Consumption Volume from 2016 to 2021
11.4.2 South Africa End-Stage Renal Disease (ESRD) Drugs Consumption Volume from 2016 to 2021
11.4.3 Egypt End-Stage Renal Disease (ESRD) Drugs Consumption Volume from 2016 to 2021
11.4.4 Algeria End-Stage Renal Disease (ESRD) Drugs Consumption Volume from 2016 to 2021
11.4.5 Morocco End-Stage Renal Disease (ESRD) Drugs Consumption Volume from 2016 to 2021
Chapter 12 Oceania End-Stage Renal Disease (ESRD) Drugs Market Analysis
12.1 Oceania End-Stage Renal Disease (ESRD) Drugs Consumption and Value Analysis
12.2 Oceania End-Stage Renal Disease (ESRD) Drugs Consumption Volume by Types
12.3 Oceania End-Stage Renal Disease (ESRD) Drugs Consumption Structure by Application
12.4 Oceania End-Stage Renal Disease (ESRD) Drugs Consumption by Top Countries
12.4.1 Australia End-Stage Renal Disease (ESRD) Drugs Consumption Volume from 2016 to 2021
12.4.2 New Zealand End-Stage Renal Disease (ESRD) Drugs Consumption Volume from 2016 to 2021
Chapter 13 South America End-Stage Renal Disease (ESRD) Drugs Market Analysis
13.1 South America End-Stage Renal Disease (ESRD) Drugs Consumption and Value Analysis
13.1.1 South America End-Stage Renal Disease (ESRD) Drugs Market Under COVID-19
13.2 South America End-Stage Renal Disease (ESRD) Drugs Consumption Volume by Types
13.3 South America End-Stage Renal Disease (ESRD) Drugs Consumption Structure by Application
13.4 South America End-Stage Renal Disease (ESRD) Drugs Consumption Volume by Major Countries
13.4.1 Brazil End-Stage Renal Disease (ESRD) Drugs Consumption Volume from 2016 to 2021
13.4.2 Argentina End-Stage Renal Disease (ESRD) Drugs Consumption Volume from 2016 to 2021
13.4.3 Columbia End-Stage Renal Disease (ESRD) Drugs Consumption Volume from 2016 to 2021
13.4.4 Chile End-Stage Renal Disease (ESRD) Drugs Consumption Volume from 2016 to 2021
13.4.5 Venezuela End-Stage Renal Disease (ESRD) Drugs Consumption Volume from 2016 to 2021
13.4.6 Peru End-Stage Renal Disease (ESRD) Drugs Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico End-Stage Renal Disease (ESRD) Drugs Consumption Volume from 2016 to 2021
13.4.8 Ecuador End-Stage Renal Disease (ESRD) Drugs Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in End-Stage Renal Disease (ESRD) Drugs Business
14.1 CTI BioPharma Corp
14.1.1 CTI BioPharma Corp Company Profile
14.1.2 CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Product Specification
14.1.3 CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Merck & Co Inc
14.2.1 Merck & Co Inc Company Profile
14.2.2 Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Product Specification
14.2.3 Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 Novartis AG
14.3.1 Novartis AG Company Profile
14.3.2 Novartis AG End-Stage Renal Disease (ESRD) Drugs Product Specification
14.3.3 Novartis AG End-Stage Renal Disease (ESRD) Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Prolong Pharmaceuticals LLC
14.4.1 Prolong Pharmaceuticals LLC Company Profile
14.4.2 Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Product Specification
14.4.3 Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 VESSL Therapeutics Ltd
14.5.1 VESSL Therapeutics Ltd Company Profile
14.5.2 VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Product Specification
14.5.3 VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global End-Stage Renal Disease (ESRD) Drugs Market Forecast (2022-2027)
15.1 Global End-Stage Renal Disease (ESRD) Drugs Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global End-Stage Renal Disease (ESRD) Drugs Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global End-Stage Renal Disease (ESRD) Drugs Value and Growth Rate Forecast (2022-2027)
15.2 Global End-Stage Renal Disease (ESRD) Drugs Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global End-Stage Renal Disease (ESRD) Drugs Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global End-Stage Renal Disease (ESRD) Drugs Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America End-Stage Renal Disease (ESRD) Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia End-Stage Renal Disease (ESRD) Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe End-Stage Renal Disease (ESRD) Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia End-Stage Renal Disease (ESRD) Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia End-Stage Renal Disease (ESRD) Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East End-Stage Renal Disease (ESRD) Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa End-Stage Renal Disease (ESRD) Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania End-Stage Renal Disease (ESRD) Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America End-Stage Renal Disease (ESRD) Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global End-Stage Renal Disease (ESRD) Drugs Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global End-Stage Renal Disease (ESRD) Drugs Consumption Forecast by Type (2022-2027)
15.3.2 Global End-Stage Renal Disease (ESRD) Drugs Revenue Forecast by Type (2022-2027)
15.3.3 Global End-Stage Renal Disease (ESRD) Drugs Price Forecast by Type (2022-2027)
15.4 Global End-Stage Renal Disease (ESRD) Drugs Consumption Volume Forecast by Application (2022-2027)
15.5 End-Stage Renal Disease (ESRD) Drugs Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
